Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Multiple Myeloma

Clinical trial condition

Recurrent Multiple Myeloma

Explore clinical trials studying Recurrent Multiple Myeloma. Study availability and eligibility vary by location and protocol.

22 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Multiple Myeloma trial results

Active, Not Recruiting

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT04883242

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

NCT04764942

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details